Evidence map›Paper›PMID 39328802›Full record

ArticleJournal of medical cases2024

Role of Continuous Drainage of Tense Ascites in Peritoneal Dialysis: Mehandru/Masud Technique.

Sushil K Mehandru, Supreet Kaur, Avais Masud, Kyrillos Rezkalla, Qalb Khan, Prit Paul Singh, Eric Constanzo, Walid Abboud, Tushar Vachharajani, Arif Asif

Abstract readCase Reports
In one paragraph

Article in Journal of medical cases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sushil K MehandruDepartment of Medicine, Division of Nephrology and Hypertension, The Mehandru Center for Innovation in Nephrology, Jersey Shore University Medical Center, Hackensack Meridian School of Medicine, Neptune, NJ, USA.
Supreet KaurDepartment of Medicine, Division of Nephrology and Hypertension, The Mehandru Center for Innovation in Nephrology, Jersey Shore University Medical Center, Hackensack Meridian School of Medicine, Neptune, NJ, USA.
Avais MasudDepartment of Medicine, Division of Nephrology and Hypertension, The Mehandru Center for Innovation in Nephrology, Jersey Shore University Medical Center, Hackensack Meridian School of Medicine, Neptune, NJ, USA.
Kyrillos RezkallaDepartment of Medicine, Division of Nephrology and Hypertension, The Mehandru Center for Innovation in Nephrology, Jersey Shore University Medical Center, Hackensack Meridian School of Medicine, Neptune, NJ, USA.
Qalb KhanDepartment of Medicine, Division of Nephrology and Hypertension, The Mehandru Center for Innovation in Nephrology, Jersey Shore University Medical Center, Hackensack Meridian School of Medicine, Neptune, NJ, USA.
Prit Paul SinghDepartment of Medicine, Division of Nephrology and Hypertension, The Mehandru Center for Innovation in Nephrology, Jersey Shore University Medical Center, Hackensack Meridian School of Medicine, Neptune, NJ, USA.
Eric ConstanzoDepartment of Medicine, Division of Nephrology and Hypertension, The Mehandru Center for Innovation in Nephrology, Jersey Shore University Medical Center, Hackensack Meridian School of Medicine, Neptune, NJ, USA.
Walid AbboudDepartment of Medicine, Division of Nephrology and Hypertension, The Mehandru Center for Innovation in Nephrology, Jersey Shore University Medical Center, Hackensack Meridian School of Medicine, Neptune, NJ, USA.
Tushar VachharajaniDepartment of Nephrology and Hypertension, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Glickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
Arif AsifDepartment of Medicine, Division of Nephrology and Hypertension, The Mehandru Center for Innovation in Nephrology, Jersey Shore University Medical Center, Hackensack Meridian School of Medicine, Neptune, NJ, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Insertion of a peritoneal dialysis (PD) catheter in end-stage renal disease (ESRD) patients with cirrhosis and tense ascites remains a challenge for nephrologists. Ascitic fluid leak at the surgical site, a common postoperative occurrence, leads to the disqualification of many patients who could be otherwise great candidates for PD. The ascitic fluid leak has been described to occur during or immediately after surgery even after the entire volume of ascitic fluid has been drained. In this study, we report a case study of three patients with ESRD, liver cirrhosis, and tense ascites on hemodialysis. The patients required super large volume paracentesis (SLVP), draining 9,000 - 15,000 cc of ascitic fluid twice weekly in an interventional radiology setup. Besides ascitic fluid drainage, the patients needed in-center hemodialysis (ICHD) 3 days a week, leading to their engagement in procedures 5 days a week. In addition, intradialytic symptomatic hypotension, hypoalbuminemia, and other adverse effects of hemodialysis lead to their poor lifestyle. To improve their lifestyle, all patients desired to switch to PD from ICHD. Upon the PD catheter insertion and drainage of the entire ascitic fluid, leaks developed at the insertion site within a few hours. To overcome these leaks, PD catheters of all three patients were attached via a transfer set to a bag for continuous drainage of ascitic fluid for about 2 weeks. No leak or complication was noted, leading to complete healing of insertion site. We recommend, for the patients with tense ascites requiring SLVP, approximately 2 weeks of healing period continuously be performed till initiation of PD training,.

Indexed as

Continuous drainageEnd-stage renal diseaseLiver cirrhosisPeritoneal dialysisSuper large volume paracentesisTense ascites

Identifiers

PMID39328802
PMCPMC11424101

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.